ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 3377.9 | 4072.1 | 2982.2 |
| Other income | 20.8 | 23.9 | 16.1 |
| Total income | 3398.7 | 4096.0 | 2998.3 |
| Profit before exceptional items & tax | 125.4 | 282.6 | 163.2 |
| Exceptional items | 9.2 | 17.5 | 0.0 |
| Profit before tax | 134.6 | 300.1 | 163.2 |
| Net profit | 102.5 | 227.2 | 120.8 |
| Operating margin | 4.0% | 7.3% | 5.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -15.10% |
|---|---|
| Net profit, quarter on quarter | -54.90% |
| Revenue, year on year | +13.30% |
| Operating profit, year on year | -28.90% |
| Operating profit, quarter on quarter | -59.60% |
BSE results filing, NSE: BLUESTARCO. Figures extracted from the filing.
Blue Star Ltd: key numbers
- Share price
- ₹1,563.80
- Market cap
- ₹32,154 Cr
- Revenue (annual)
- ₹12,402 Cr
- Net profit (annual)
- ₹527.7 Cr
- P/E (TTM)
- 60.2×Sector 44.3×
- Promoter holding
- 36.50%+0.00% QoQ
- FII holding
- 12.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Star Ltd
All →Blue Star Employee Stock Options
Blue Star granted 6,520 stock options to an employee under its ESOP 2024 scheme. Options vest over four years at ₹2 per option.
- Execution
- Vesting in four 25% instalments at 12, 24, 36 and 48 months; exercisable within 7 years of grant
Blue Star Debt & Borrowing: ₹200 Cr
Blue Star Limited announced record dates for the maturity of listed Commercial Papers totaling Rs. 200 Crore. Redemption is scheduled across three tranches in November 2026.
- Value
- ₹200.0 Cr
Blue Star Legal & Regulatory
Blue Star's Dubai Court of Appeal dismissed WJT's application to annul the arbitration award in the company's favour. WJT may still appeal the award.
- Value
- ₹461.7 Cr
Blue Star Earnings Call Transcript: Key Takeaways
Management is prioritizing margin recovery over market share following a disappointing Q1. While RAC volumes surged, inability to fully pass on 18% raw material inflation continues to depress segment margins.
- Call
- Guides 25% growth
Blue Star Investor Presentation: Key Takeaways
Q2FY27 revenue ₹2,931 cr (+21%), PAT ₹124 cr (+25%, incl. ₹23 cr MedTech exit gain); EBITDA +10.5%, margins squeezed in Unitary and projects.
Blue Star Management Change
Blue Star Ltd appointed Mr Nithianand S and Mr Senthil Thangam as Senior Management Personnel effective November 1, 2026. This is a leadership change disclosed under Regulation 30.